carfilzomib

Carfilzomib (868540-17-4) Carfilzomib is used in the treatment of refractory multiple myeloma. This pharmaceutical compound is associated with a low rate of serum enzyme elevations during treatment and has been implicated in rare instances of clinically apparent, acute liver injury, some of which have been fatal. Product Specifications Product Name: Carfilzomib CAS No.: 868540-17-4 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C40 H57 N5 O7